Johnson & Johnson buy AlleAktien
Start price
02.03.22
/
0%
€150.38
Target price
02.03.23
-
Performance (%)
-4.80%
End price
03.03.23
€143.16
Summary
This prediction ended on 03.03.23 with a price of €143.16. With a performance of -4.80%, the BUY prediction by AlleAktien finished with a loss. A total of €4.35 was paid as dividends for this prediction. This prediction was marked as speculative and is excluded from AlleAktien's performance statistics.Johnson Johnson is a multinational company that focuses on the development, manufacturing, and marketing of a wide range of consumer health products, medical devices, and pharmaceuticals. The company was founded in 1886 and is headquartered in New Jersey, USA. It operates in more than 60 countries and has a diverse portfolio of popular brands including Band-Aid, Tylenol, and Neutrogena. As of 2021, Johnson Johnson has a market capitalization of over $435 billion and is listed on the New York Stock Exchange under the symbol JNJ.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Johnson & Johnson | -0.044% | -0.044% | -9.124% |
| iShares Core DAX® | 1.051% | -1.833% | 12.822% |
| iShares Nasdaq 100 | -0.547% | -3.738% | 40.625% |
| iShares Nikkei 225® | -1.778% | -8.115% | 16.092% |
| iShares S&P 500 | 0.002% | -2.226% | 28.387% |
Comments by AlleAktien for this prediction
In the thread Johnson & Johnson diskutieren
In unserem Artikel Johnson & Johnson Update: ist die Abspaltung gesund oder drohen Probleme? beschreiben wir, warum Johnson & Johnson unserer Meinung nach interessant ist. Viel Spaß beim Lesen.
In the thread Trading Johnson & Johnson
Die von AlleAktien gewählte maximale Laufzeit wurde überschritten
News
Johnson & Johnson Update: ist die Abspaltung gesund oder drohen Probleme?
Johnson & Johnson Aktie und Aktienanalyse
Hauptsitz
New Brunswick, USA
ISIN
US4781601046
WKN
853260
Ticker-Symbol
JNJ
Sektor
Gesundheit
Kurs
166,0 USD
Ausstehende Aktien
2.674
